AAAAAA

   
Results: 1-16 |
Results: 16
A 2ND UNRELATED BONE-MARROW TRANSPLANT WITH AN UNRELATED DONOR MARROW- TREATMENT OF A PATIENT WITH RELAPSED LEUKEMIA
Authors: BASARA N BISCHOFF M BLAU IW HERMANN D ROMER E RUDOLPHI M KIRSTEN D SANCHEZ H FAUSER AA
Citation: N. Basara et al., A 2ND UNRELATED BONE-MARROW TRANSPLANT WITH AN UNRELATED DONOR MARROW- TREATMENT OF A PATIENT WITH RELAPSED LEUKEMIA, Bone marrow transplantation, 21(3), 1998, pp. 291-293
ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION DOES NOT INCREASE THE INCIDENCE AND SEVERITY OF ACUTE GRAFT-VERSUS-HOST DISEASE - EXPERIENCE WITH 52 FAMILY RELATED AND UNRELATED MARROW DONOR TRANSPLANTS
Authors: BLAU IW HERRMANN D SCHMETZER B ROEMER E BISCHOFF M FAUSER AA
Citation: Iw. Blau et al., ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION DOES NOT INCREASE THE INCIDENCE AND SEVERITY OF ACUTE GRAFT-VERSUS-HOST DISEASE - EXPERIENCE WITH 52 FAMILY RELATED AND UNRELATED MARROW DONOR TRANSPLANTS, Bone marrow transplantation, 21, 1998, pp. 10-10
ALLOGENEIC BMT PBSCT IN PATIENTS WITH RELAPSED OR REFRACTORY LEUKEMIAAND LYMPHOMA - A SINGLE INSTITUTION EXPERIENCE/
Authors: KIRSTEN D BLAU IW BASARA N RUDOLPHI M BISCHOFF M ROEMER E FAUSER AA
Citation: D. Kirsten et al., ALLOGENEIC BMT PBSCT IN PATIENTS WITH RELAPSED OR REFRACTORY LEUKEMIAAND LYMPHOMA - A SINGLE INSTITUTION EXPERIENCE/, Bone marrow transplantation, 21, 1998, pp. 136-136
MULTIORGAN FAILURE (MOF) AS THE MOST FREQUENT CAUSE OF EARLY TRANSPLANT-RELATED MORTALITY (TRM)
Authors: ROEMER E BLAU IW BISCHOFF M GUNZELMANN S RUDOLPHI M KIRSTEN D FAUSER AA KIEHL MG
Citation: E. Roemer et al., MULTIORGAN FAILURE (MOF) AS THE MOST FREQUENT CAUSE OF EARLY TRANSPLANT-RELATED MORTALITY (TRM), Bone marrow transplantation, 21, 1998, pp. 320-320
DIAGNOSTIC YIELD OF BRONCHOALVEOLAR LAVAGE (BAL) AND TRANSBRONCHIAL BIOPSY (TBB) IN PATIENTS AFTER ALLOGENEIC BRIT
Authors: RUDOLPHI M BLAU IW ROMER E BISCHOFF M FAUSER AA KIEHL MG
Citation: M. Rudolphi et al., DIAGNOSTIC YIELD OF BRONCHOALVEOLAR LAVAGE (BAL) AND TRANSBRONCHIAL BIOPSY (TBB) IN PATIENTS AFTER ALLOGENEIC BRIT, Bone marrow transplantation, 21, 1998, pp. 507-507
SUCCESSFUL TREATMENT OF CEREBRAL TOXOPLASMOSIS FOLLOWING ALLOGENEIC BMT PBSCT/
Authors: ROEMER E BLAU IW BISCHOFF M GUNZELMANN S SANCHEZ H RUDOLPHI M KIRSTEN B GENGENBACHER D FAUSER AA
Citation: E. Roemer et al., SUCCESSFUL TREATMENT OF CEREBRAL TOXOPLASMOSIS FOLLOWING ALLOGENEIC BMT PBSCT/, Bone marrow transplantation, 21, 1998, pp. 518-518
SEVERE COMPLICATION AFTER ALLOGENEIC BMT - PNEUMOTHORAX AND MEDIASTINAL EMPHYSEMA IN A PATIENT WITH BOOP (BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA)
Authors: RUDOLPHI M BASARA N FAUSER AA BLAU IW
Citation: M. Rudolphi et al., SEVERE COMPLICATION AFTER ALLOGENEIC BMT - PNEUMOTHORAX AND MEDIASTINAL EMPHYSEMA IN A PATIENT WITH BOOP (BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA), Bone marrow transplantation, 21, 1998, pp. 557-557
BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA (BOOP) AFTER ALLOGENEICBONE-MARROW TRANSPLANTATION (BMT)
Authors: RUDOLPHI M ROMER E BISCHOFF M KIRSTEN D GUNZELMANN S KIEHL MG BLAU IW FAUSER AA
Citation: M. Rudolphi et al., BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA (BOOP) AFTER ALLOGENEICBONE-MARROW TRANSPLANTATION (BMT), Bone marrow transplantation, 21, 1998, pp. 558-558
IMPACT OF HLA-MISMATCH FOR GRAFT-VERSUS-HOST DISEASE AND CHIMERISM INUNRELATED BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME
Authors: GENGENBACHER DM BLAU IW ROEMER E RUDOLPHI M BISCHOFF M KIRSTEN D SANCHEZ H GUENZELMANN S THIELE B FAUSER AA
Citation: Dm. Gengenbacher et al., IMPACT OF HLA-MISMATCH FOR GRAFT-VERSUS-HOST DISEASE AND CHIMERISM INUNRELATED BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME, Human immunology, 55, 1997, pp. 129-129
CLINICAL-SIGNIFICANCE OF DRUG-RESISTANCE AND CELL-CYCLE ANALYSIS IN ACUTE-LEUKEMIA DURING CHEMOTHERAPY AND ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: GENGENBACHER DM ROMANAKIS R SCHMETZER B GUENZELMANN S BENDER M HERRMANN D BLAU IW BISCHOFF M SANCHEZ H ROEMER E THIELE B RUDOLPHI M KIRSTEN D FAUSER AA
Citation: Dm. Gengenbacher et al., CLINICAL-SIGNIFICANCE OF DRUG-RESISTANCE AND CELL-CYCLE ANALYSIS IN ACUTE-LEUKEMIA DURING CHEMOTHERAPY AND ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 90(10), 1997, pp. 3639-3639
ANALYSIS OF THE INCIDENCE AND SEVERITY OF ACUTE GRAFT-VERSUS-HOST DISEASE IN PATIENTS UNDERGOING ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION - A SINGLE INSTITUTION OF 55 FAMILY RELATED AND UNRELATED MARROW DONOR TRANSPLANTS
Authors: BLAU IW HERRMANN D SCHMETZER B GENGENBACHER DM BISCHOFF M BASARA N FAUSER AA
Citation: Iw. Blau et al., ANALYSIS OF THE INCIDENCE AND SEVERITY OF ACUTE GRAFT-VERSUS-HOST DISEASE IN PATIENTS UNDERGOING ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION - A SINGLE INSTITUTION OF 55 FAMILY RELATED AND UNRELATED MARROW DONOR TRANSPLANTS, Blood, 90(10), 1997, pp. 4396-4396
INDUCTION OF GRAFT VERSUS LYMPHOMA REACTION IN STAGE IV B-CELL NON-HODGKINS-LYMPHOMA AFTER ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANT- COMPARISON OF LABORATORY, RADIOLOGICAL AND CLINICAL FINDINGS
Authors: RUDOLPHI M BASARA N BISCHOFF M BLAU IW GENGENBACHER DM GUNZELMANN S SCHMETZER B HERRMANN D ROMER E KIRSTEN D SANCHEZ H FAUSER AA
Citation: M. Rudolphi et al., INDUCTION OF GRAFT VERSUS LYMPHOMA REACTION IN STAGE IV B-CELL NON-HODGKINS-LYMPHOMA AFTER ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANT- COMPARISON OF LABORATORY, RADIOLOGICAL AND CLINICAL FINDINGS, Blood, 90(10), 1997, pp. 4475-4475
MATCHED UNRELATED AND RELATED BONE-MARROW TRANSPLANTATION FOR HIGH-RISK MYELODYSPLASTIC SYNDROME AND SECONDARY ACUTE MYELOID-LEUKEMIA
Authors: GENGENBACHER DM BISCHOFF M GUENZELMANN S ROEMER E KIRSTEN D RUDOLPHI M SANCHEZ H BASARA N BLAU IW FAUSER AA
Citation: Dm. Gengenbacher et al., MATCHED UNRELATED AND RELATED BONE-MARROW TRANSPLANTATION FOR HIGH-RISK MYELODYSPLASTIC SYNDROME AND SECONDARY ACUTE MYELOID-LEUKEMIA, Blood, 90(10), 1997, pp. 4528-4528
ANALYSIS OF TRANSPLANTATION RELATED MORTALITY (TRM) OF 65 PATIENTS ATHIGH-RISK RECEIVING A MUD BONE-MARROW AND OR A PERIPHERAL STEM-CELL TRANSPLANT - A SINGLE INSTITUTION EXPERIENCE/
Authors: KIRSTEN D BLAU IW BASARA N BISCHOFF M GENGENBACHER D FAUSER AA
Citation: D. Kirsten et al., ANALYSIS OF TRANSPLANTATION RELATED MORTALITY (TRM) OF 65 PATIENTS ATHIGH-RISK RECEIVING A MUD BONE-MARROW AND OR A PERIPHERAL STEM-CELL TRANSPLANT - A SINGLE INSTITUTION EXPERIENCE/, Blood, 90(10), 1997, pp. 4531-4531
ANTIFUNGAL PROPHYLAXIS IN NEUTROPENIC CAN CER-PATIENTS AND ALLOGENEICBONE-MARROW TRANSPLANTATION
Authors: BLAU IW FAUSER AA
Citation: Iw. Blau et Aa. Fauser, ANTIFUNGAL PROPHYLAXIS IN NEUTROPENIC CAN CER-PATIENTS AND ALLOGENEICBONE-MARROW TRANSPLANTATION, Mycoses, 39, 1996, pp. 81-86
CLINICAL-RESULTS OF BONE-MARROW TRANSPLANTATION IN COMBINATION WITH CD34(-BLOOD STEM-CELLS IN HIGH-RISK PATIENTS WITH LEUKEMIA() SELECTED PERIPHERAL)
Authors: BLAU IW SERR A SCHILZ A SCHMETZER B HERRMANN D BENDER M BISCHOFF M ROEMER E FAUSER AA
Citation: Iw. Blau et al., CLINICAL-RESULTS OF BONE-MARROW TRANSPLANTATION IN COMBINATION WITH CD34(-BLOOD STEM-CELLS IN HIGH-RISK PATIENTS WITH LEUKEMIA() SELECTED PERIPHERAL), Experimental hematology, 24(9), 1996, pp. 131-131
Risultati: 1-16 |